Share on Facebook
Share on Twitter
Share on LinkedIn
Share by Email
Print
Fullterm Generic Name & Formulations
Legal Class
PP
General Description
In vitro test; fetal fibronectin enzyme immunoassay.
How Supplied
Contact supplier.
Manufacturer
Fullterm Indications
Indications
Aid in assessing risk of preterm delivery in ≤7 or ≤14 days from the time of cervicovaginal sample collection in women with signs/symptoms of early preterm labor, intact amniotic membranes, and minimal cervical dilation (<3cm), sampled between ≥24 weeks and <35 weeks gestation. Aid in assessing risk of preterm delivery in <35 weeks during routine prenatal visit between 22 weeks and <31 weeks gestation in women with singleton gestation.
Fullterm Dosage and Administration
Fullterm Contraindications
Not Applicable
Fullterm Boxed Warnings
Not Applicable
Fullterm Warnings/Precautions
Warnings/Precautions
See literature. Not for women with advanced cervical dilatation, ruptured amniotic membranes, cervical cerclage, moderate or gross vaginal bleeding. Collect vaginal sample before any activities that may disrupt cervix (eg, coitus, cervical examinations, vaginal ultrasound, pap smear).
Fullterm Pharmacokinetics
See Literature
Fullterm Interactions
Interactions
Lubricants, soaps, disinfectants may interfere with test results.
Fullterm Adverse Reactions
Not Applicable
Fullterm Clinical Trials
See Literature
Fullterm Note
Not Applicable
Fullterm Patient Counseling
See Literature
